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DyneinBim is a BH3-only member of the Bcl-2 family that enables the death of T-cells. Partial rescue of cytokine-
deprived T-cells occurs when Bim and the receptor for the T-cell growth factor, interleukin-7, are deleted, im-
plicating Bim as a possible target of interleukin-7-mediated signaling. Alternative splicing yields three major
isoforms: BimEL, BimL and BimS. To study the effect of Bim deﬁciency and deﬁne the function of the major
isoforms, Bim-containing and Bim-deﬁcient T-cells, dependent on interleukin-7 for growth, were used.
Loss of total Bim in interleukin-7-deprived T-cells resulted in delayed apoptosis. However, loss of Bim also
impeded the later degradative phase of autophagy. p62, an autophagy-adaptor protein which is normally de-
graded, accumulated in Bim deﬁcient cells. To explain this, BimL was found to support acidiﬁcation of lyso-
somes that later may associate with autophagic vesicles. Key ﬁndings showed that inhibition of lysosomal
acidiﬁcation accelerated death upon interleukin-7 withdrawal only in Bim-containing T-cells. intereukin-7
dependent T-cells lacking Bim were less sensitive to inhibition of lysosomal acidiﬁcation. BimL co-
immunoprecipitated with dynein and Lamp1-containing vesicles, indicating BimL could be an adaptor for dy-
nein to facilitate loading of lysosomes. In Bim deﬁcient T-cells, lysosome-tracking probes revealed vesicles of
less acidic pH. Over-expression of BimL restored acidic vesicles in Bim deﬁcient T-cells, while other isoforms,
BimEL and BimS, promoted intrinsic cell death. These results reveal a novel role for BimL in lysosomal posi-
tioning that may be required for the formation of degradative autolysosomes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cell death is an essential process needed for tissue homeostasis. Cen-
tral to the modulation of apoptotic death are members of the B-cell
lymphoma-2 (Bcl-2) family, which includes pro-survival proteins, such
as Bcl-2 and Bcl-xL, pro-apoptotic members, like themulti-domain pro-
teins, Bax and Bak, and a number of BH3-only proteins, such as Bad, Bid,
Bim or Bmf [1]. Of the BH3-only proteins, Bim emerges as an important
regulator of T-lymphocyte (T-cell) apoptosis. Bim is necessary for the
death of autoreactive T-cells and is upregulated in T-cells upon death in-
duced by T-cell receptor re-stimulation or growth factor withdrawal
[2,3]. Therefore, the key to understanding Bim's role in the apoptotic
program is appreciating its relationship to T-cells.
In order to receive stimulatory and growth signals, T-cells need to
migrate to environments where these signals are found [4]. An example
of one essential signal is the cytokine, interleukin-7 (IL-7). IL-7 ismainly
found in generative lymphoid organs as well as some nonlymphoidical Sciences, College of Medi-
lvd, Orlando, FL 32827, USA.
).
rights reserved.tissues [5] and is produced in large part by accessory cells [6,7]. The
heterodimeric IL-7 receptor (IL-7R), composed of both IL-7Rα and γc
chains, is expressed by T-cells [8]. IL-7 is necessary for T-cell develop-
ment, since disruption of either IL-7 or its receptor resulted in defects
in mice [9,10] similar to the SCID (Severe Combined Immunodeﬁciency
Syndrome) phenotype in humans [11]. Evidence of the importance of
IL-7 is the fact that excess IL-7 underlies lymphoproliferation and lym-
phoma formation [12,13], indicating a role in themaintenance of periph-
eral T-cell homeostasis [14]. IL-7 supports T-cell survival by maintaining
a balance between the anti-apoptotic and pro-apoptotic Bcl-2 family
members [15,16]. Indicative of a function in T-cell biology, loss of Bim
could partially rescue the immunodeﬁcient phenotype of IL-7R−/−
mice [17].
How the activity of Bim is regulated remains the focus of study. In
some healthy cells, Bim is sequestered by LC8, the light chain element
of the microtubule-associated dynein motor complex [18,19] or is
bound to anti-apoptotic proteins such as Bcl-2 or Bcl-xL at the mito-
chondrial interface aswas shown in T-cells [20]. Other regulatorymech-
anisms include transcriptional regulation by FHKR (forkhead) through
Foxo3a [21,22], the gastric tumor suppressor, RUNX [23], or the post-
translational phosphorylation of Bim at multiple sites [24–30]. We re-
cently showed that IL-7 mediates the phosphorylation of BimEL,
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pro-apoptotic protein is well-recognized, Bim may also have unknown
functions that go beyond its described death-promoting activity. Bim
exists as multiple isoforms generated through alternative splicing,
with the three major isoforms, BimEL, BimL, and BimS, part of a larger
cohort of spliced forms [32,33]. Some isoforms lack the BH3 domain or
the dynein light-chain binding site, while others lack phosphorylation
sites [34], which could result in the possibility that isoforms may have
different functions.
When extracellular nutrient sources are limiting, autophagy can sup-
port T-cell activation through intracellular scavenging [35], but, under
less well-understood conditions, autophagy can also induce T-cell
death, for example that of CD4 T-cells [36]. The individual contribution
of themajor isoforms of Bim to the processes of autophagy or apoptosis
in T-cells is unknown. To study this, we used Bim-containing and Bim-
deﬁcient T-cells, responsive to IL-7, to examine the activity of the
major isoforms in response to the cytokine. A novel role in lysosome po-
sitioning was found for BimL that was dependent upon IL-7 and
supported the degradative phase of autophagy. In contrast, BimEL and
BimS promoted IL-7 withdrawal-induced apoptosis. These results dem-
onstrated that Bim isoforms can participate in distinct apoptotic and
lysosomal/degradative activities in T-cells. While Bim has long been
recognized as an inducer of apoptosis, its role in supporting lysosome
acidiﬁcation suggests that controlled manipulation of Bim isoforms
could lead to novel applications in diseases like cancer.2. Materials and methods
2.1. Mice, cell lines and culture reagents
C57BL/6micewere purchased from Jackson Laboratory (Bar Harbor,
Maine) and housed at the University of Central Florida, Orlando, FL.
Bim knockout (BimKO) mice (C57BL/6 background) [31], Rag−/− and
IL-7−/−/Rag−/− mice were housed at NCI-Fredrick as previously de-
scribed [31]. This study was carried out in accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocolwas approved by the In-
stitutional Animal Care and Use Committee at the University of Central
Florida and NCI-Frederick. All efforts were made to minimize suffering.
The IL-7 dependent T-cell line, D1, was established from one clone
that arose from T-cells isolated from a p53−/−mouse and immortalized
as previously described [37]. Since its establishment in 1997, the D1 cell
line has been extensively used to study regulatory pathways controlled
by IL-7 in T-cells [16,38–41] and was used to reveal the role of IL-7 in
the phosphorylation of BimEL [31]. To uncover the functional conse-
quences of Bim deﬁciency and evaluate the function of each Bim isoform,
weneeded a T-cell line thatwas IL-7 dependent and also Bimdeﬁcient. To
this end, we generated the SMoR T-cell line. Brieﬂy, lymph node T-cells
were isolated from BimKO mice (see above). Cells were resuspended in
RPMI 1640, 10% fetal bovine serum (FBS), 5% Penicillin/Streptomyocin
(Fisher), 0.1% B-mercaptoethanol (Invitrogen) (complete medium), and
200 ng/ml IL-7 at a concentration of 5×105 cells/ml. Using twenty 96-
well, round bottom plates, 100 μl or approximately 104 cells/well were
plated. In total, almost 2×107 cells were used formutagenesis as follows.
Ethyl-N-nitrosurea (0.64 mM, ENU) in phosphate/citrate buffer was
added to the cultures at 0, 7, 14, 21, and 28 days from initial isolation.
Mutagenized T-cells were grown with complete media and IL-7. After
3 months, one BimKO T-cell clone emerged that was immortalized and
IL-7-dependent. This outcome recapitulated the same result observed
when the original D1 cell line was cloned, in that a single line emerged
from the selection process for IL-7 dependency [37]. This experience
showed that generating immortalized IL-7 dependent T-cells is not possi-
ble unless underlying mutations, such as Bim or p53 deﬁciency, are pre-
sent. D1 and SMoR T-cell lines, both derived from mice with a C56BL/6
background, were grown in complete medium and 50–200 ng/ml IL-7.Early passages of D1 and SMoR cell lines were frozen as stocks and cells
were used at less than 10 passages from stocks.
Primary lymph node (LN) and splenic T-cells were isolated from
both wild-type (WT) and BimKO C57BL/6 mice as previously de-
scribed [42]. Phoenix cells (see below) were maintained in DMEM
medium that was supplemented with 10% FBS.
Reagents used as described in the ﬁgure legends include piﬁthrin-
α (p53 inhibitor) (Sigma-Aldrich), 3-methyladenine (3-MA) (class III
phosphatidylinositol 3-kinase (PI3K) inhibitor) (Sigma-Aldrich), ca-
thepsin III Inhibitor (pan cathepsin inhibitor, EMD), pepstatin A (ca-
thepsin D inhibitor, EMD) and Ca074 (cathepsin B inhibitor, EMD)
and chloroquine (CQ) diphosphate salt (Sigma-Aldrich).
2.2. Viability and proliferation assays
To quantitate cells undergoing apoptosis, the FITCAnnexin-VApopto-
sis Detection Kit (BD Pharmingen) was used following manufacturer's
protocol. This kit utilizes a FITC-conjugated Annexin-V antibody that
recognizes phosphatidyl serine exposed on cells undergoing early apo-
ptosis, and contains PI (propidium iodide) which can permeate necrotic,
membrane-damaged cells. The Annexin-V/PI kit could not be used with
cells expressing GFP (see Section 2.9) as the kit contains a FITC-
conjugated antibody whose emissions would overlap the emission of
GFP-containing cells. To address this, the SYTOX® AADvanced™ dead
cell stain solution and the Violet Ratiometric Membrane Asymmetry
Probe/Dead Cell Apoptosis Kit (Invitrogen) was used following the man-
ufacturer's protocol. Apoptosis was indicated by membrane asymmetry
using the violet ratiometric dye, and membrane permeability was mea-
sured by Sytox uptake. Sytox was visualized at 488 nm and emissions
were collected at 695 nm. The violet ratiometric probe was visualized
at 405 nm and emissions were collected at 450 nm and 510 nm. Cells
were analyzed by ﬂow cytometry using the BD FACSCanto II ﬂow
cytometer. Analysis was completed using FCSExpress (DeNovo) soft-
ware. Viability was also assessed by determiningmorphological changes,
cell shrinkage and granularity, using forward scatter (FSC) and side scat-
ter (SSC) gating by ﬂow cytometry with an Accuri C6 ﬂow cytometer.
Proliferation was measured by labeling cells with CFSE as previ-
ously described [42–44]. For CFSE labeling, one million cells were
treated with 2 μM CFSE (Molecular Probes) staining solution (PBS+
0.1% BSA) for 10 min and then washed to remove excess label. The di-
vision of cells was determined by measuring CFSE ﬂuorescence by
ﬂow cytometry after 72 h of culture with or without IL-7. The gener-
ation number for the population was determined from a best ﬁt of
these data using the proliferation module for the FCS Express soft-
ware (DeNovo). Unstimulated CFSE-containing cells were used to de-
termine the peak corresponding to the undivided population.
2.3. Bim inhibition by small interfering RNAs
One-to-two million D1 cells were treated with 1–2 nM BCL2L11
SMART pool siRNA (Dharmacon) and Accell delivery media (Dhar-
macon) supplemented with 1% FBS, and IL-7 (50 ng/ml) for 24 h.
After 24 h, cells were deprived of IL-7 and re-plated in media con-
taining the siRNA alone, for 48 h. SMART pool siRNA contains four se-
quence variations of siRNAs to eliminate non-speciﬁc interactions.
Non-targeting siRNA (NT siRNA) containing a FAM reporter sequence
was used as a delivery control, and was comparable to treatment with
Accell media alone. Cells were analyzed using ﬂow cytometry and
confocal microscopy.
2.4. Quantitative PCR
Ten million D1 cells, per experimental condition, cultured with or
without IL-7 as described above, were re-suspended in 1 ml of TRIzol
reagent (Invitrogen). Total RNAwas extracted from the cells using the re-
agent according to the manufacturer's instructions. Each cDNA template
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cDNA Synthesis kit according to the manufacturer's instructions. Quanti-
tative analysis of cDNA ampliﬁcation was assessed by incorporation of
SYBR Green (ABI 4385370) into double-stranded DNA. To detect mouse
Bim: forward 5′-CGACAGTCTCAGGAGG AACC-3′ and reverse 5′-
CCTTCTCCATACCAGA CGGA-3′ primers were used. To detect β-actin as
control, forward primer 5′-GAAA TCGTGCGTGACATCAAAG-3′ and re-
verse primer 5′-TGTAG TTTCATGGATGCCACAG-3′ were used. Reactions
contained Fast SYBR Green Master mix (1×), β-actin primers at 50 nM
or Bim primers at 100 nM, and 3–4 μg cDNA template. Thermal cycling
conditions were as follows: 40 cycles of 30 s at 95 °C followed by 45 s
at 57 °C, and 60 s at 72 °C, denaturing, annealing and extension
temperatures, respectively. All cDNA samples were processed using the
ABI Fast 7500 and analyzed using ABI Sequence Detection Software Ver-
sion1.4. The difference inmRNAexpressionwas calculated as follows: RQ
value or fold change=2−ΔΔCt. ΔΔCt is equal to the change in ΔCt values
over time after normalization toβ-actin.ΔCt is equal to the difference be-
tween the endogenous control Ct and target gene Ct values.
2.5. Immunoprecipitation and immunodetection
For preparation of whole cell lysates, 37–45 million cells were
lysed using the Cell Lysis buffer (Cell Signaling) in the presence of
protease inhibitors (Roche). In the case of primary cells, 1 to 3 million
cells per condition, were used. For immunoprecipitation, cell lysates
were pre-cleared with Protein A/G Sepharose beads (Santa Cruz), in-
cubated with anti-dynein antibody and immunoblotted for Lamp1
and Rab5 as described below. For immunoblotting, subcellular frac-
tions (from gradients, see Section 2.11), whole cell lysate samples,
or co-immunoprecipitated samples were run in 10% or 12–15% SDS-
PAGE gels, and proteins were transferred to nitrocellulose mem-
branes by semi-dry transfer (BioRad) or wet transfer (Novex) follow-
ing the manufacturers' protocols. Membraneswerewashed andprobed
with primary antibodies (see below) and incubated with horseradish
peroxidase (HRP)-conjugated (Santa Cruz) or ﬂuorescence-conjugated
secondary antibodies (LICOR). Signal was detected using either chemilu-
minescent fempto substrate (SuperSignal West Fempto, ThermoSci) or
the LICOR Odyssey detection system. The primary antibodies used in
this study were as follows: a rabbit polyclonal antibody against amino
acids 22 to 40 of human Bim protein (anti-Bim, Calbiochem), Bim (rat
monoclonal 14A8, Calbiochem), Lamp1 (mouse monoclonal 1D4B; de-
veloped by J. Thomas August, Developmental Studies Hybridoma Bank,
University of Iowa), prohibitin (rabbit polyclonal ab28172, Abcam), p38
(Santa Cruz), Bcl-2 (Santa Cruz), Rab5, an early endosome marker
(Abcam), cathepsin B (Abcam), dynein (Abcam), p62 (Cell Signaling),
and LC3B (Abcam). Quantitation of the bands was performed using
ImageJ software, taking the average of three separate measurements for
each band.
2.6. Cell surface protein analysis
Surface expression of IL-7R expressed on T-cells was assessed by
ﬂow cytometry using a PE-conjugated anti-IL-7R antibody (BD Biosci-
ences) as previously described [42–44]. A PE-conjugated isotype
matched antibody was used as a control for non-speciﬁc staining.
One–two million D1 or SMoR cells were incubated with or without
IL-7 for 18 h and then treated with saturating amounts of the appro-
priate antibody for 20 min, washed in buffer (PBS+0.1% BSA) and an-
alyzed by ﬂow cytometry on the Accuri C6 ﬂow cytometer.
2.7. Measurement of intracellular pH
Cells (D1, SMoR, primary C57BL/6 and BimKO) were resuspended in
Hanks buffer supplemented with 25 mM HEPES (Invitrogen), 1% FBS,
and 1 μM BCECF-AM (Molecular Probes). Intracellular pH-dependent
changes in ﬂuorescence were measured by ﬂow cytometry, usingmethods previously described [45,46]. To establish a pH calibration
curve, a separate group of cells (D1, SMoR, primary C57BL/6 and
BimKO) was re-suspended in high-potassium HEPES buffer (25 mM
HEPES, 145 mM KCl, 0.8 mM MgCl2, 5.5 mM glucose, and DDH2O) at
pH standards (5.9, 6.5, 7.0, 7.2, and 7.8) and nigericin (10 μM) was
added followed by BCECF-AM. Measurements were acquired using a
BD FACSCanto II cytometer excited with a 488 nm laser, with emissions
ﬁltered through 525 nm and 610 nm. Dead cells were excluded by
forward- and side-scatter gating. pH values were determined by mea-
suring the absorbance ratio between 525 nm (green ﬂuorescence) and
610 nm (redﬂuorescence), the latter ofwhich compensates for dye con-
centration, volume, and cell size.
2.8. Live cell imaging/microscopy
For imaging, cells were plated in 24-well glass bottom dishes
(MatTek) that had beenwashed with 1 N HCl and PBS. Cells were treat-
ed with 1 μM LysoSensor immediately before imaging. LysoSensor
probe is cell membrane permeable and exhibits pH-dependent changes
in ﬂuorescence intensity. For imaging of retrovirus-infected cells, dishes
were coatedwith 8 μg/ml Retronectin (Takara), followed by the retrovi-
ral supernatant, prior to adding cells. At 20 h post-infection, 1 μM
LysoTracker (Molecular Probes) was added to cell culture in RPMI com-
plete media immediately prior to imaging. LysoTracker probes are also
cell membrane permeant and contain a ﬂuorophore bound to a weak
base that becomes partially protonated upon neutral pH exposure and
selectively stains acidic organelles in live cells, although ﬂuorescence
is independent of pH changes. Fluorescent images were acquired with
the UltraView spinning disk confocal system (PerkinElmer) with
AxioObserver.Z1 (Carl Zeiss) stand, and a Plan-Apochromat 40×/1.4
Oil DIC objective. Z-stacks and extended focus of scanned images were
created and modiﬁed using the Volocity 5.5 image processing program
(PerkinElmer). LysoSensor-treated samples were excited at 405 nm.
To detect LysoSensor ﬂuorescence, emissions between 445 nm and
615 nm were collected for more neutral pH vesicles (assigned an arbi-
trary yellow color), and between 525 nm and 640 nm for more acidic
vesicles (assigned an arbitrary blue color). LysoTracker stained samples
were excited at 561 nm and emissions collected between 525 nm and
640 nm. Transmitted light images were collected for DIC. For SMoR
cells expressing pMIG, BimEL, or BimL plasmids, total ﬂuorescence and
the number of GFP positive events, with the removal of auto ﬂuorescent
outliers, per ﬁeld, were obtained using Volocity 5.5. GFP was acquired
using a 488 nm laser, and emissions were collected at 525 nm and
640 nm.
2.9. Retroviral transfection
The bi-cistronic plasmids, pMIG, pEco, BimEL-pMIG, BimS-pMIG,
and BimL-pMIG were made as previously described [31]. The retrovi-
ral infection technique was optimized speciﬁcally for the D1 and
SMoR cell lines [31]. A Phoenix-Eco packaging cell line (Orbigen)
was transfected with bi-cistronic plasmids containing a Bim isoform
(or none, termed pMIG) and GFP. Cells were transfected using
TransIT-LT1 reagent (Mirus). The supernatant containing the retrovi-
rus was harvested after 48 h and loaded onto Retronectin (Takara)-
coated plates. 1,000,000 cells/ml were incubated in supplemented
media containing Polybrene (Santa Cruz, 8 μg/ml), either in the pres-
ence or absence of IL-7, and added to the plates for several hours.
2.10. Adoptive transfer of T-cells and chloroquine in vivo treatment
C57BL/6 and BimKO LN cells were isolated and suspended in PBS
containing 5% FBS. Cells were incubated for 10 min with CFSE (Invi-
trogen) following previously established methods [31]. Rag−/−/IL-
7−/− double knockout or Rag−/− recipient mice were irradiated
with 3 Gy whole body γ-irradiation 4 h prior to injection. Five million
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ferred into the previously irradiated Rag−/−, and Rag−/−/IL-7−/−
double knockout mice. Mice were intraperitoneally injected with
60 mg/kg chloroquine within 24 h, and again, after 48 h. Mice were
euthanized within 72 h, spleens and lymph nodes were recovered,
and T-cells were isolated and utilized for analysis as previously men-
tioned [43]. Recovered cells were analyzed for loss of CFSE label by
ﬂow cytometry (Accuri C6 ﬂow cytometer) and calculation of gener-
ation times was performed using FSC Express (DeNovo) proliferation
module software.
2.11. Subcellular fractionation
Cells were seeded to 80–90% conﬂuence. For lysosome prepara-
tions: 200 mg (140million) cells were harvested by isotonic lysis buff-
er according to protocol from the Lysosome Enrichment Kit (Pierce)
and prepared for density gradient ultracentrifugation. Enriched lyso-
somal fractions were layered onto an iodixanol gradient (17%, 23%,
25%, 27%, 29%, and 30% Optiprep) and subjected to ultracentrifugation
using an Optima L-100XP Ultracentrifuge. Fractions from gradients
were collected in 500 μl aliquots (fractions 1–10) using an Auto
Densi-Flow (Labconco). Enriched preps were utilized for downstream
processing or re-suspended in sample buffer for gel-electrophoresis
(see below).
2.12. Statistics
Statistical analysis and signiﬁcance were determined using Prism 5
(Graphpad) for Windows, Version 5.02. P values determined are
shown in the ﬁgure legends.
3. Results
3.1. Bim has multiple functions, promoting death as well as growth in IL-
7 responsive cells
It is generally accepted that Bim inhibits the survival activity of
anti-apoptotic members of the Bcl-2 family [47], and that it has an im-
portant, although poorly understood, role in T-cell biology [17]. Our
previous studies showed that in T-cells, IL-7 regulated the activity of
BimEL through phosphorylation [31], but the activity of other major
isoforms, BimL and BimS, relative to IL-7 signaling, remained un-
known. Using primary LN T-cells from C57BL/6 or BimKO mice, we
evaluated the effect of in vitro culture with IL-7, using methods we
previously established [42,43]. Shown in Fig. 1A are representative re-
sults indicating in the absence of IL-7 that loss of Bim provided short
term protection (3 days), although such LN cells eventually died in in
vitro culture. Viability of cells was determined by assessing cell
shrinkage and increased granularity detected by forward scatter
(FSC) and side scatter (SSC) gating using ﬂow cytometry. Because pri-
mary T-cells do not uniformly respond to an IL-7 signal (i.e. CD8 T-
cells proliferative at the expense of CD4 T-cells) [42,43] and may
need additional signals through the T-cell receptor (TCR) for optimal
growth [48], we used an IL-7-dependent T-cell line, D1, to examine
the activity of Bim in response to IL-7. The generation of the D1 cell
line has been previously described [37] and a number of studies
have demonstrated its biological relevance in the context of IL-7 sig-
naling [16,38–41,49]. Upon IL-7 withdrawal, cell death, as indicated
by increased Annexin-V/PI staining, was detected in D1 cells within
36 h, and death was maximal by 48 h (Fig. 1B) [37]. To determine
whether loss of Bim could protect D1 cells from IL-7 deprivation,
cells were treated with Bim siRNA, to inhibit total Bim. We observed
a 40% reduction in Bim mRNA levels in cells treated with Bim siRNA
as compared to cells treated with control siRNA (Fig. 1C). Note that
the siRNA methodology limits cell numbers to a few million, which
is below the threshold for detection of endogenous Bim protein. ThesiRNA-induced decrease in Bim expression led to reduced apoptosis
in D1 cells deprived of IL-7 as indicated by the increased percentage
of viable cells (Annexin-V/PI negative) detected (Fig. 1C). For this
experiment, D1 cells were incubated with siRNAs for 72 h, the ﬁrst
24 h of which was in the presence of IL-7 and the last 48 h was in
the absence of IL-7. To determine whether IL-7 regulated the gene ex-
pression of Bim, we examined the levels of total BimmRNA in D1 cells
cultured with or without IL-7. Using quantitative PCR, we observed
that Bim mRNA levels increased in the absence of IL-7 — speciﬁcally
after 15–18 h of cytokine withdrawal, indicating that the gene ex-
pression of Bim, was in part, IL-7 responsive (Fig. 1D). These results
supported the conclusion that Bim was among the effectors of death
in response to IL-7 deprivation.
To evaluate the biological consequence of Bim deﬁciency in IL-7-
dependent T-cells and study the function of each major isoform with-
out the limitations imposed by either primary lymphocyte cultures or
siRNA treatments, we needed a Bim-deﬁcient and IL-7-dependent T-
cell line. To this end, we generated the SMoR T-cell line from BimKO
mice as described in Materials and methods. To demonstrate that
the expression of Bcl-2 family members in D1 or SMoR cells was not
altered by either the immortalization process or loss of p53 or Bim,
we examined Bcl-2 and Bax, proteins whose expression or activity,
respectively, is regulated by IL-7 [16,37,50]. As shown in Fig. 2A, we
found that the two cell lines displayed minimal differences in the
amounts of Bcl-2 or Bax detected in response to IL-7. Bcl-2 levels de-
creased in the absence of IL-7 and Bax distributed between the cyto-
sol andmitochondria (Fig. 2A). Next, we determined whether, lacking
functional Bim, SMoR cells underwent death upon IL-7 withdrawal.
Apoptosis was detected using Annexin-V/PI staining, and viability
was determined by assessing changes in cell size and granularity.
Shown in Fig. 2B and C, we observed decreased numbers of
Annexin-V/PI positive SMoR cells after 36 h of IL-7 deprivation and
sustained viability (50–60%) through 48 h of IL-7 loss. These results
indicated that IL-7-dependent, Bim-deﬁcient SMoR cells are useful
for the study of Bim function in IL-7 dependent T-cells and conﬁrmed
that Bim was contributing to death induced by IL-7 loss.
As shown and previously reported, D1 cells underwent death be-
tween 24 and 48 h after IL-7 withdrawal (Fig. 2C) [37]. Stimuli that in-
duce apoptosis can also trigger DNA damage and p53 is usually
responsive to this mechanism [51]. To show that protection from IL-
7-withdrawal-induced death in SMoR cells was likely due to loss of
Bim and not the presence of a possible p53-mediated activity, we
treated cells with piﬁthrin-α, originally described as a p53 inhibitor
[52], but also shown to protect from DNA-damage induced apoptosis
[53]. No differences in the viability of SMoR cells or D1 cells, cultured
with IL-7, were detected upon piﬁthrin treatment (Supplemental Fig.
1). Withdrawal of IL-7 and the addition of piﬁthrin increased the
death observed in D1 cells, suggesting that both p53-dependent and
p53-independent death mechanisms were involved. In contrast,
SMoR cells were resistant to death induced by increasing doses of
piﬁthrin-α (Supplemental Fig. 1), indicating that the loss of Bim was
likely a key factor that contributed to protective effect observed
upon IL-7withdrawal (Fig. 2C). Note that upon extended IL-7 depriva-
tion, SMoR cells eventually died after 4 days (data not shown). Hence,
the loss of Bim did not prevent but delayed the death of cells deprived
of IL-7.
Other parameters of importance are cytokine-driven proliferation
and viability under conditions of nutrient deprivation. To measure the
growth of D1 and SMoR cells in response to IL-7, we used the dye,
CFSE. CFSE divides with each cell replication cycle and can be used
to measure generation times as shown in Fig. 2D. D1 cells rapidly di-
vided in response to IL-7, replicating 1–2 times per day over the three
days of evaluation, while SMoR cells divided 1–2 times over the same
three day period (Fig. 2D). Therefore, loss of Bim, while providing
protection from IL-7-induced cell death (Fig. 2C), decreased cell rep-
lication rate. The surface expression of the IL-7R was measured to
AD
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Fig. 1. Loss of Bim partially protects IL-7 dependent cells from apoptosis. (A) Lymph node T-cells, isolated fromWT C57BL/6 or BimKO mice and cultured with or without 150 ng/ml
of IL-7 for 3 days as described in Materials and methods, were assessed for viability as determined by cell morphology, assessing size (forward scatter (FSC)) and granularity (side
scatter (SSC)) by ﬂow cytometry. (B) Cytokine withdrawal-induced death of D1 cells, grown with or without 50 ng/ml IL-7 (36 h), was measured by surface expression of phos-
phatidyl serine using FITC-conjugated Annexin-V antibody. Membrane permeability was assessed by propidium iodide exclusion (PI), analyzed by ﬂow cytometry. Dot plots
show percentages representing the population of cells that are non-apoptotic (lower left quadrant), early apoptotic (upper left quadrant) or late apoptotic/necrotic (upper right
quadrant). Quadrants were established using controls. (C) D1 cells were pre-treated with non-targeting control or BCL2L11 SMART pool siRNA (Dharmacon) for 24 h with IL-7.
Cells were then deprived of IL-7 for 48 h. Efﬁcacy of Bim siRNA upon Bim mRNA levels (graph) was established by measuring total Bim gene expression by quantitative PCR in
which RQ value (or fold change in gene expression)=2−ΔΔCt. IL-7-withdrawal-induced death in D1 cells, treated with either non-targeting control (control) or Bim siRNA, is
shown (dot plots) using Annexin-V/PI staining as described above. (D) Total Bim gene expression in D1 cells, in the presence or absence of IL-7, was measured for the times indi-
cated by quantitative PCR. RQ (Fold change)=2−ΔΔCt. Data shown in this ﬁgure are representative of a minimum of three independent experiments. * Pb0.05, **Pb0.0241,
***Pb0.0001.
1881S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893determine whether the slow growth of SMoR cells was due to de-
creased IL-7R levels. This was not observed, as is shown in Fig. 2E.
Both D1 and SMoR cells displayed comparable levels of IL-7R that in-
creased upon cytokine withdrawal, a pattern that is typical of what
others have reported [54]. In fact, compared to D1 cells, SMoR cells
had slightly higher amounts of surface IL-7R relative to maximal re-
ceptor levels achieved in the absence of IL-7 (Fig. 2E). SMoR cells,
but not D1 cells, were also more sensitive to glucose deprivation
and decreased viability when cultured under conditions of minimal
glucose (4 mM) (Fig. 2F). These results suggested that loss of Bim
conferred partial protection from cell death caused by growth factor
removal but also caused a growth disadvantage that resulted in re-
duced replication and sensitivity to nutrient loss that was not depen-
dent on the levels of IL-7R.3.2. Bim supports intracellular acidiﬁcation and formation of acidic
vesicles
In order to investigate the activity of Bim in IL-7 dependent T-cells
that could account for the observed biological effects, changes in intra-
cellular pHwere examined. Cytosolic acidiﬁcation can be a hallmark of
apoptosis and has been linked with lysosomal proton release upon ly-
sosomal permeabilization [55,56]. Changes in pH can also correlate
with proliferative status [57]. A time course experiment, measuring
intracellular pH, showed that D1 cells acidify after 24–30 h of IL-7
withdrawal, consistent with morphological changes that are indica-
tive of cell death (Fig. 3A). In SMoR cells, IL-7 deprivation did not in-
duce acidiﬁcation and cells remained more alkaline over the entire
course of evaluation (Fig. 3A). These results were conﬁrmed using
Fig. 2. Characterization of SMoR cells. (A) Expression of Bcl-2 and Bax in D1 and SMoR cells, cultured with or without IL-7 for 18 h, was examined by immunoblot. Prohibitin and
p38 MAPK are shown as loading controls for mitochondrial and cytosolic content, respectively. (B) Cytokine-withdrawal-induced death of SMoR cells, grown with or without IL-7
(36 h), was measured using FITC-conjugated Annexin-V antibody and PI as previously described. (C) Viability of D1 and SMoR cell lines, without IL-7 for the hours indicated, was
determined by assessing morphological changes using FSC and SSC gating as previously described. (D) CFSE labeled D1 and SMoR cells were cultured with IL-7 for 72 h. Generation
or doubling time, as indicated by loss of CFSE label, was assessed by ﬂow cytometry as described in Materials and methods. Histograms display the ﬂuorescence proﬁle of CFSE-
labeled cells analyzed using FCS Express Proliferation software (DeNovo). The percent of cells in the peak generation for each cell line is shown. Lines indicate undivided cells
and peaks indicate divided cells. Tables at the far right display the number of generations within the experimental period for each cell line. (E) Histograms show the surface ex-
pression of IL-7R in D1 and SMoR cells in the presence or absence of IL-7 for 18 h, using a speciﬁc PE-conjugated anti-IL-7 antibody, analyzed by ﬂow cytometry. Table shows
the mean for each peak and the percent of IL-7R expression compared to the maximum level achieved in the absence of IL-7. (F) D1 and SMoR cells were cultured in the presence
of IL-7 and limiting concentrations of glucose for 114 h. Viability was determined by cell morphology, assessing size (forward scatter (FSC)) and granularity (side scatter (SSC)) by
ﬂow cytometry. Results shown are representative of three experiments. * Pb0.05, ***Pb0.0001.
1882 S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893LN T-cells from WT and BimKO mice (Fig. 3B). While we previously
showed that D1 cells transiently alkalinize 6–8 h after IL-7 withdrawal
due to the activity of the sodium hydrogen exchanger 1 (NHE1) [16],
this is an active mechanism induced by apoptotic stimulus [45]. In con-
trast, the increased intracellular pH of SMoR cells was detectable in the
presence of IL-7 and did not change even during IL-7 withdrawal.These data suggested that Bim losswas affecting a biological activity
that impacted upon intracellular pH. One possibility could be that the
loss of Bimdisruptednormal lysosomal functioning. Todeterminewheth-
er the morphology of lysosomes was different in Bim-containing and
Bim-deﬁcient cells, endosomes and lysosomes were visualized using the
LysoSensor probe. LysoSensor measures the pH of acidic organelles and
Fig. 3. The distribution of acidic vesicles is altered in absence of Bim. (A) Intracellular pH of D1 and SMoR cell lines was measured in the absence of IL-7 at times indicated in the
ﬁgure using ﬂow cytometric analysis of BCECF-AM ﬂuorescence, assessing the ratio at 525 nm and 610 nm. Results were determined from calibrated pH standards as described in
Materials and methods. (B) Lymph node T-cells isolated from WT C57BL/6 or BimKO mice, either freshly isolated (fresh) or cultured with 150 ng/ml of IL-7 (cultured) for 4 days,
were assessed for pH, as determined by ﬂow cytometric analysis of BCECF-AM ﬂuorescence described above. (C–E) Live cell confocal microscopy images of D1 cells (C) in the pres-
ence or absence of IL-7 for 20 h are shown. Cells were loaded with LysoSensor as described in Materials and methods. IL-7-deprived D1 cells, containing either non-targeting control
(NT) or Bim siRNA (D), were loaded with LysoSensor and imaged as described above. SMoR cells (E) grown with or without IL-7 were loaded with LysoSensor and imaged as de-
scribed above. Yellow color indicates ﬂuorescence of intracellular vesicles at a more neutral pH acquired at emissions 445/615, and blue color indicates ﬂuorescence of vesicles at
acidic pH acquired at 525/640 nm. Colors were arbitrarily chosen. Fluorescent images were obtained using the UltraView spinning disk confocal system (PerkinElmer) with
AxioObserver.Z1 (Carl Zeiss) stand, and a Plan-Apochromat 40×/1.4 Oil DIC objective. For (C–E), images were obtained from Z-series collections and 3D projections developed
using Velocity software. Arrows indicate regions of interest or intensity/merged vesicle staining. Images are representative “snapshots” of three or more independent experiments.
***Pb0.001.
1883S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893distinguishes more neutral vesicles of higher pH (i.e. endosomes) from
acidic or lower pH vesicles (i.e. late endosomes/lysosomes). In parallel
studies, the probe LysoTracker was used to visualize lysosomal contentand show that no pH-dependent changes in the probe occurred in the or-
ganelles imaged, demonstrating that LysoTracker staining and LysoSensor
staining were comparable (Supplemental Fig. 2). Live cell imaging was
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Fig. 4. Treatmentwith 3-MA accelerated cell death induced by IL-7 withdrawal but not in
Bim deﬁcient cells. D1 and SMoR cells, culturedwith orwithout IL-7 for 18 h, were treated
with 3-MA (5 mM) as described in Materials and methods. Cell death was assessed by
measuring phosphatidyl serine surface exposure and membrane permeability with a
FITC-conjugated Annexin-V antibody and PI staining using ﬂow cytometry. Dot plots
show percentages representing the population of cells that are non-apoptotic (lower
right quadrant), early apoptotic (upper right quadrant) or late apoptotic/necrotic (upper
left quadrant). Quadrants were established using controls. Results shown are representa-
tive of four independent assays.
1884 S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893performed to view results from lysosome probes. In Fig. 3C, using
LysoSensor, we observed a difference in the distribution and aggregation
of less acidic (arbitrarily assigned a yellow color) compared tomore acidic
vesicles (arbitrarily assigned a blue color) in D1 cells grownwith orwith-
out IL-7. The dispersed distribution of acidic vesicles within cells cultured
with IL-7 became clumped and aggregated as IL-7 was deprived, indicat-
ing a potential increase in endosome/lysosome fusion. This is best ob-
served in the 3-dimensional (3D) single-cell enlargement showing
intense staining of merged ﬂuorescent signals (appearing white in
areas) from acidic vesicles (Fig. 3C). When D1 cells were treated with
Bim siRNA, a distinct change was observed in that aggregation was de-
creased (no intense staining of merged ﬂuorescence or white areas)
and increased detection of less acidic vesicles (Fig. 3D). This ismost clear-
ly seen in the merged 3D enlargement. These results suggested that loss
of Bim had a negative effect upon the distribution of acidic vesicles. This
was conﬁrmed in SMoR cells with increased detection of less acidic vesi-
cles (Fig. 3E) in thepresence or absence of IL-7. In total, increased intracel-
lular alkalinity and decreased acidic vesicles in Bim deﬁcient cells
suggested that Bim could have a function in themaintenance of lysosom-
al activity.
3.3. The absence of Bim leads to impairment of the later degradative
phase of autophagy
Our data showing that SMoR cells lacking Bim were less viable
under conditions of limiting glucose (Fig. 2F) and has less acidic vesi-
cles (Fig. 3E), suggested that Bim could be involved in a novel biolog-
ical activity, that of self-eating or autophagy. Autophagic digestion can
contribute to the recycling of cytoplasmic components and promote
survival, the inhibition of which may enhance apoptosis [58]. Alterna-
tively, autophagy can directly lead to cell death [59]. To examine this,
we used the class III PI3K inhibitor, 3-MA, which can inhibit autophagy
under conditions of nutrient or cytokine deprivation [60]. We ob-
served that 3-MA treatment accelerated cell death in the absence of
IL-7 — from 32% (untreated) to 49% (3-MA) apoptotic/necrotic cells
(Fig. 4). Treatment with 3-MA had only a minor impact in Bim deﬁ-
cient SMoR cells and did not greatly increase the percent of apopto-
tic/necrotic cells — from 8% (untreated) to 12% (3-MA) (Fig. 4). We
also observed that treatment with 3-MA caused some death in the
presence of IL-7 (Fig. 4), which could be due to the effect of this inhib-
itor on PI3 Kinases [60].
To assess autophagic activity, the levels of LC3-I and LC3-II were
measured. LC3-I is cytosolic, while LC3-II, which is conjugated with
phosphatidylethanolamine (PE), is associated with autophagosomes
and less so with autolysosomes [61,62]. Normally the amount of LC3-II
correlates with the number of autophagosomes and is degraded as a re-
sult of autophagy. As shown in the representative experiment in Fig. 5A,
LC3-I and LC3-II levels varied slightly in D1 cells cultured with IL-7 for 6
or 18 h, withmore LC3-I and less LC3-II detected at 18 h. In contrast, D1
cells deprived of IL-7 for 6 h (or at 18 h) had an increased ratio of LC3-II
to LC3-I, suggesting an increased number of autophagosomes (Fig. 5A).
In comparison, SMoR cells displayed higher amounts of both LC3-I and
LC3-II, suggesting that either autophagosomes were increased in these
cells or that degradation of LC3was reduced, allowing the protein to ac-
cumulate (Fig. 5A). Note that by 18 h of IL-7 deprivation, levels of LC3-I
and IIwere negligible in bothD1 and SMoR cells. Next, we examined the
degradation of p62 (a.k.a. SQSTM1) as an indicator of autophagic ﬂux.
The targeting of p62 to the autophagosome formation site does not re-
quire LC3, however, once there, p62 binds to LC3 and is entrapped in
autophagosomes where, upon fusion with lysosomes, it is degraded
[63]. Hence, impairment of the degradative phase of autophagy can re-
sult in the accumulation of p62. We observed that in D1 cells, the levels
of p62 declined when IL-7 was withdrawn, suggestive of increased
autophagic degradation (Fig. 5A). This did not occur in SMoR cells
where p62 levels remained elevated (Fig. 5A). We conﬁrmed these re-
sults using freshly isolated LN T-cells from BimKO and WT mice. Incomparison to WT cell, we detected elevated levels of LC3-II compared
to LC3-I in BimKO cells, with a greatly increased ratio of LC3-II to LC3-I
and increased accumulation of p62 (Fig. 5B). This data suggested that
loss of Bim did not impair autophagosome formation, since LC3-II and
p62 were detected, but could suggest a problem with the degradative
phase of autophagy that allowed these proteins to accumulate.
To study lysosomal-mediated degradative activity, we used the in-
hibitor, chloroquine (CQ), to inhibit lysosomal acidiﬁcation. As a com-
parison, we also used 3-MA. Within the timeframe of the experiment
with freshly isolated LN cells, these inhibitors did not greatly impact
upon LC3 and p62 protein levels (Fig. 5B). However, inhibition of lyso-
somal acidiﬁcation with CQ did increase LC3-II accumulation in D1
cells grown with or without IL-7 (Fig. 5C) and also increased the
amount of p62 (Fig. 5D), indicating that these proteins were being de-
graded as a result of lysosomal activity. Treatment with 3‐MA had a
similar, though slightly lesser, effect (Fig. 5C–D). This suggested that
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Fig. 5. The degradative phase of autophagy is impaired by Bim loss. (A)D1 and SMoR cellswere grownwith orwithout IL-7 for 6 or 18 h, andwhole cell lysateswere prepared as described in
Materials andmethods. Lysateswere immunoblottedwith speciﬁc antibodies for LC3 to examine levels of LC3-I and LC3-II as well as p62. Quantitation of bandswas performed using Image J
software and is the average of 3 measurements taken per band. p38 MAPK is included as a loading control. Protein levels of LC3 and p62 were normalized to p38 MAPK and percentages of
protein detected are shown relative to samples from D1 cells cultured 18 h with IL-7. Results shown are representative of three independent experiments. (B) Whole cell lysates were pre-
pared from primary LN cells freshly isolated fromWT and BimKO mice and immunoblotted for LC3 and p62 as described above. Cells were treated with 3-MA (5 mM) or chloroquine (CQ)
(25 μM) for 6 hprior to lysis. p38MAPK is shownas a loading control and quantitation of bandswas performed as described in (A)with percentages of protein shown relative to untreatedWT
cells. (C–D) D1 and SMoR cells were cultured with or without IL-7 for 6 h and treated with 3-MA or CQ as described above. Lysates were immunoblotted for LC3 (C) and p62 (D) following
protocols described above. p38MAPK is shown as a loading control for each blot and quantitation of bandswas determined as described in (A)with percentages of proteins shown relative to
D1 cells untreated and cultured with IL-7. Results are representative of three independent experiments. Images from full-length blots were cropped for concise presentation.
1885S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893in Bim-containing D1 cells, autophagosome formation was occurring,
followed by autolysosomal-mediated protein degradation. In SMoR
cells CQ treatment also caused some accumulation of LC3-II but to alesser extent than in D1 cells (Fig. 5C). As example, in D1 cells cultured
with IL-7, CQ treatment caused an almost three-fold increase in LC3-II as
compared to SMoR cells in which a slightlymore than two-fold increase
1886 S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893was observed (Fig. 5C). Note also that in SMoR cells, higher levels of
LC3-I were found that resulted in lower ratios of LC3-II to LC3-I. The
amount of p62 protein was also elevated in SMoR cells and was not sig-
niﬁcantly increased by CQ or 3‐MA treatments (Fig. 5D). These results
supported the idea that Bim is needed to enable the degradativephase of autophagy, impairment of which could have a negative feed-
back upon the initiation of autophagy and LC3 conversion levels.
To strengthen the conclusion that the lysosomal/degradative
phase of autophagy is defective in Bim-deﬁcient cells, SMoR cells
were treated with inhibitors of cathepsin activity or lysosomal
1887S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893acidiﬁcation. The expectation was that Bim deﬁciency would render
SMoR cells resistant to the effect of these inhibitors. In Fig. 6A, a rep-
resentative experiment with SMoR cells is shown in which treat-
ments with a pan-cathepsin inhibitor (CI) had little effect on IL-7-
withdrawal induced apoptosis. Results were conﬁrmed with speciﬁc
inhibitors of aspartic proteases, like cathepsin D (pepstatin A) and ca-
thepsin B (Ca074) (Fig. 6B). With the autophagy process intact, D1
cells showed the anticipated effect of accelerated cell death upon CI
(Fig. 5A) and pepstatin A (Fig. 5B) treatments. Note that inhibitors
of speciﬁc cathepsins were less effective than the pan-cathepsin in-
hibitor (CI), likely because the speciﬁc cathepsins inhibited were
less active in these cells. To further examine the effect of Bim upon
the lysosomal activity, CQ was used [64]. CQ is being tested as a ther-
apeutic agent and is well-tolerated at treatment doses [65]. A CQ
dose–response curve was experimentally determined (data not
shown). The representative experiment in Fig. 6C revealed that in the
presence of IL-7, CQ caused less death in SMoR cells, and, upon IL-7with-
drawal, SMoR cells were resistant to the effects of CQ and did not
accumulate large numbers of late-apoptotic/necrotic cells. As expected,
Bim-containing, D1 cells underwent accelerated IL-7-induced apoptosis
upon CQ treatment, with increased amounts of apoptotic/necrotic cells
detected, as measured by Annexin-V/PI staining (Fig. 6C). These results
suggested that the autophagy defect in Bim-deﬁcient cells might be as-
sociated with the formation of degradative autolysosomes. Findings in
Fig. 3, that SMoR cells were more alkaline and accumulated fewer acidic
vesicles provide additional support for this idea.
Studies performed with T-cell lines were extended to mice to
determine whether inhibition of lysosome acidiﬁcation accelerated
the death of WT, but not BimKO, T-cells adoptively transferred to
Rag−/−IL-7−/− mice. Recipient Rag−/− (control) or Rag−/−IL-7−/−
mice were treated with CQ as described in Materials and methods,
and splenic CFSE-labeled T-cells were recovered for analysis. Genera-
tion or doubling time was determined by the number of cycles in
which the CFSE label was halved during each cell division. Results are
shown in Fig. 6D–E. We observed that WT T-cells transferred to control
Rag−/−mice proliferated equally well in the absence or presence of CQ
(Fig. 6D). The same was true with BimKO T-cells, although the total cell
number was slightly reduced during CQ treatment (Fig. 6E). When WT
cells were transferred to Rag−/−IL-7−/−mice, proliferation was greatly
reduced and a signiﬁcant number of cells remained undivided (Fig. 6D).
Moreover, loss of Bim did not rescue T-cell expansion in the absence of
IL-7 (Fig. 6E). However, CQ treatment did complement Bim deﬁciency
and restored T-cell growth in mice lacking IL-7 (Fig. 6E). Note that we
observed a similar ﬁnding in that SMoR cells were more resistant to
CQ treatment (Fig. 6C). CQ treated WT T-cells transferred to Rag−/−IL-
7−/− mice did not proliferate and fewer cells were recovered than
was observed for untreated WT cells under IL-7-deﬁcient conditions
(Fig. 6D). These results conﬁrmed the in vitro results described for T-
cell lines (Fig. 6C) that inhibition of lysosomal activity can accelerate
death during an apoptotic stimulus, like IL-7 withdrawal, and that this
does not occur in cells lacking Bim.Fig. 6. Bim deﬁcient cells are resistant to inhibition of lysosomal activity. (A) Cytokine-wit
(vehicle control) or 50 μM pan-cathepsin inhibitor (cathepsin inhibitor III (CI)) was measur
tibody. Membrane permeability was assessed by propidium iodide exclusion (PI) and analyz
that are non-apoptotic (lower left quadrant), early apoptotic (upper left quadrant) or late
(B) D1 and SMoR cells cultured without IL-7 and either DMSO (vehicle control), 5 μMpepstat
were assessed for viability as determined by cell morphology, assessing size (forward scatte
cultured with IL-7 or without IL-7 and 25 μM chloroquine (25CQ) were assayed for Annexin
population of cells indicated by the highlighted boxes of late apoptotic or necrotic cells. R
adoptively transferred to either Rag knockout (Rag−/−) or IL-7/Rag double knockout (IL-7
untreated or treated with chloroquine (CQ) (i.p. 60 mg/kg/mouse) 24 and 48 h after transfe
The number of generations recovered from transferred WT cells (D) and BimKO cells (E)
DeNovo). Representative results from duplicate experiments are shown.3.4. Bim isoforms differentially contribute to apoptotic and lysosomal
activities
The results obtained indicated that Bim could have possible roles
supporting both apoptosis and the degradative, lysosomal-mediated
phase of autophagy. The question remained — how can Bim function
in both capacities? A possible answer could be that Bim isoforms have
different roles in these processes. To determine this, we examined the
expression of the major isoforms of Bim in response to IL-7. To local-
ize the major Bim isoforms, BimEL, BimL and BimS, to organelles, den-
sity gradient separation of cell lysates was performed. This procedure
allows the separation of organelles and membrane-encased vesicles
based upon lipid and protein content. In Fig. 7A, a representative ex-
periment shows that in Bim-containing D1 cells, cultured with IL-7,
we detected BimL protein in fraction 3 that is associated with late
endosomes/lysosomes and marked by the highest concentration of
Lamp1 (fractions 1–4). Note that Lamp1 is diagnostic for lysosomal-
associated disorders [66] and thus a marker for lysosome content. A
small amount of the early endosome marker, Rab5, also associated
with the same fraction. As a control, we observed that Bcl-2 associat-
ed with those fractions in which prohibitin, a mitochondrial marker,
was found (fractions 3–5, but highest in fraction 4) as well as small
amounts of the other major Bim isoforms (Fig. 7A).
Performing gradient centrifugation using cell lysates from IL-7-
deprived D1 cells, we detected increased amounts of BimEL and BimS
that associated with mitochondrial fractions marked by Bcl-2 and
prohibitin (fractions 3–6, but mostly in fraction 4) and decreased
amounts of BimL that associatedwith lysosomes (Fig. 7A). Interestingly,
more BimEL was seen across fractions 1–5, while BimL and BimS were
concentrated in the mitochondrial-associated fractions. We also ob-
served an increase in Lamp1 staining in the lightest density fraction
(fraction 1) and aweak but dispersed distribution of Rab5. These results
demonstrated that the isoforms of Bim could localize to different organ-
elles based on the lipid/protein content in the presence of IL-7 as com-
pared to the absence of IL-7. Signiﬁcantly, we found that BimL was
associated with lysosome fractions in the presence of IL-7.
In Fig. 7B, similar density gradient experiments performed with
SMoR cells are shown. Overall Lamp1 levels were reduced in the ligh-
ter density fractions (fraction 3 in the presence of IL-7 and fraction 1
in the absence of IL-7). While Lamp1 staining was decreased, Rab5
staining was increased, which supported the imaging experiments
in Fig. 3 and suggested that early endosomes (or more neutral vesi-
cles) were more abundant in the absence of Bim. Like in D1 cells,
Bcl-2 in SMoR cells was mainly associated with mitochondrial frac-
tions (Fig. 7B). Note that SMoR cells, like freshly isolated BimKO LN
and spleen cells (see Supplemental Fig. 3), express polypeptides
that migrate in a gel at the same levels of endogenous BimL and BimS.
The results shown indicated that BimL may directly associate with
lysosomes in IL-7 cultured cells. This could occur through association
with the microtubule motor, dynein. Previous studies had shown an
interaction between Bim and dynein that sequestered that BH3-onlyhdrawal induced death of D1 and SMoR cells cultured without IL-7 and either DMSO
ed by surface expression of phosphatidyl serine using a FITC-conjugated Annexin-V an-
ed by ﬂow cytometry. Dot plots show percentages representing the population of cells
apoptotic/necrotic (upper right quadrant). Quadrants were established using controls.
in A (cathepsin D inhibitor), or 10 μM Ca074 (cathepsin B inhibitor) for times indicated,
r (FSC)) and granularity (side scatter (SSC)) by ﬂow cytometry. (C) D1 and SMoR cells
-V/PI staining by ﬂow cytometry as described above. Percentages shown represent the
esults shown are representative of four experiments. (D–E) CFSE-labeled T-cells were
−/−/Rag−/−) that were irradiated as described in Materials and methods. Mice were
r of cells. Mice were sacriﬁced after 72 h and organs were analyzed for T-cell recovery.
was determined by loss of CFSE label using cell proliferation software (FCS Express,
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Fig. 7. BimL associates with lysosomes through interactions with dynein. (A) A representative immunoblot is shown of lysates enriched for lysosomal content from D1 cells. D1 cells
were cultured in the presence or absence of IL-7 for 20 h and subjected to differential ultracentrifugation. Gradient fractions (17–30% Optiprep fractions, fractions 1–10), whole cell
lysate (W), pellets after initial centrifugation step (P), and supernatant after initial centrifugation (S), were immunoblotted for Lamp1 (late endosome and lysosomal membrane),
prohibitin (mitochondria), Rab5 (early endosome), Bcl-2, and Bim. (B) Enriched lysosomal protein lysates which were prepared from SMoR cells cultured in the presence or ab-
sence of IL-7 for 20 h as described for D1 cells above (A) were analyzed by immunoblot. Blots are representative of nine independent experiments. (C) Immunoblots show co-
immunoprecipitation of dynein with Lamp1 upon presence of BimL. As input controls, the whole cell lysates before immunoprecipitation are included. Whole cell lysates of D1
and SMoR cells were cultured with or without IL-7 for 20 h incubated with either dynein or control antibody to co-immunoprecipitate binding proteins, subjected to SDS-PAGE
and immunoblotted for lysosomal/late endosomal protein (Lamp1), and early endosomal content (Rab5). (D) Whole cell lysates of SMoR cells transfected with retrovirus to express
individual Bim isoforms as described in Materials and methods, co-immunoprecipitated with either dynein or control antibody, were immunoblotted for lysosomal/late endosomal
protein (Lamp1), early endosomal protein (Rab5), and Bim. For immunoblots displayed in B-D, a representative experiment of three performed is shown. Images from full-length
blots were cropped for concise presentation.
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cilitated the binding of lysosomes to dynein, we performed a co-
immunoprecipitation experiment. Lysates were prepared from D1
cells cultured with IL-7 and immunoprecipitated with an anti-dynein
antibody. Blots were probed for Lamp1 as indicator of lysosome cargo.
As shown in Fig. 7C, dynein co-immunoprecipitated with Lamp1 in D1
cells grown with IL-7. We could not co-immunoprecipitate dynein
with Lamp1 in SMoR cells grown with or without IL-7 or with D1 cells
deprived of IL-7 — basically, cells lacking or with reduced content of
BimL. As control, we found that Rab5 associated with dynein indepen-
dently of IL-7 or Bim (Fig. 7C). Additionally, we observed that all the
immunoprecipitated versions of Lamp1 and Rab5 ran slightly slower
on the gels indicating possible modiﬁcations that enable complex for-
mation. Also, the stronger detection of Lamp1 in the input lanes for
SMoR cells as compared to other blots was due to signiﬁcantly
increased amount of protein input used to maximize detection of
co-immunoprecipitates.
Next, BimEL and BimL were expressed in SMoR cells using a retro-
viral method. This method necessitated reduced numbers of cells as
compared to blots in Fig. 7A–C. Shown in the representative experi-
ment in Fig. 7D, we found that expression of BimL, but not BimEL,
was able to restore the interaction of dynein with Lamp1-containing
vesicles in SMoR cells, signiﬁcantly increasing the detection of
Lamp1 (and some Rab5) well above endogenous levels. Thus, BimL
could function as an adaptor for dynein to facilitate the loading and
fusion of lysosomes within cells.
The role of BimL, as mediator of lysosomal positioning through its
interaction with dynein, was examined by expressing the three
isoforms of Bim in SMoR cells, and observing the effects upon lyso-
somal distribution and cell viability. To perform these experiments
we used the probe, LysoTracker. Because we were imaging GFP posi-
tive cells to track those that were expressing the isoforms of Bim, we
could not use LysoSensor as in Fig. 3 since the ﬂuorescent signals
overlapped. We used the same live cell imaging technique as shown
in Fig. 3. In addition, in each image set, a dot plot displays cell death
measured by Sytox uptake and membrane asymmetry. Images were
collected at the ﬁnal experimental time point. Results in Fig. 8A dem-
onstrated that SMoR cells expressing the empty vector, pMIG, had
dim LysoTracker staining, and viability upon retroviral expression
was 62%. When BimEL was expressed, we noticed some lysosomal
staining with little or no vesicle aggregation (Fig. 8B), and viability
decreased to 45%. In contrast, expression of BimL resulted in notable
lysosomal aggregation, likely indicative of fusion (Fig. 8C), with via-
bility stable at about 49–50%. For comparison, we also expressed
BimS, which was the most toxic of the isoforms, causing rapid cell
death with most of the GFP positive cells in the ﬁeld acquiring a
shrunken and apoptotic morphology (Fig. 8D), and viability dropping
to 30%.
4. Discussion
In this study, using Bim-containing and Bim-deﬁcient T-cells, we
examined the function of Bim during apoptosis and the degradative
phase of autophagy controlled by IL-7 stimulation and determined
that the major isoforms of Bim contribute independently to these
processes. We found that BimL may facilitate lysosomal positioning
in cells responding to IL-7 through interactions with dynein. We
also observed that loss of IL-7 up-regulated total Bim transcription,
and that Bim deﬁciency partially protected these cells from death in-
duced by IL-7 withdrawal, suggesting that the other isoforms partici-
pated in the intrinsic pathway of apoptosis. In support, we found that
T-cells lacking functional Bim had decreased growth rate, increased
endosomal and reduced lysosomal content, and were resistant to
the effects of cathepsin inhibition or impairment of lysosomal acidiﬁ-
cation. Over-expression of BimL in Bim deﬁcient cells increased vesic-
ular aggregation, while BimEL, and more so BimS, overexpressionincreased apoptotic morphology. Taken together, these results dem-
onstrated that the major isoforms of Bim could have distinct activities
in T-cells that were indicated by localization to different organelles.
Based on our studies, and others, it can be surmised that T-cells
lacking Bim would be deﬁcient in the ability of lysosomes to degrade
intracellular contents. Hence, Bim-deﬁcient T-cells would not effec-
tively degrade autophagic vesicles or initiate lysosome-mediated ap-
optotic events [68]. As a result, Bim deﬁcient T-cells could be delayed
from undergoing cell death, but, lacking the lysosomal degradative
machinery, they would eventually succumb perhaps to nutrient dep-
rivation or metabolic suicide. It is also possible that a limited form of
autophagy could occur in the absence of Bim. Under some conditions,
the contents of autophagic vesicles can be degraded by amphisomes,
autophagic vacuoles formed through the fusion of endosomes to
autophagosomes [69]. In Bim-deﬁcient cells, we detected increased
amounts of Rab5, an early endosome marker, suggesting that the fu-
sion of early endosomes was possible and could, during autophagy,
perhaps form amphisomes in the absence of forming autolysosomes.
There is also the possibility that with reduced lysosomal activities,
degradation via the proteosome could be impaired [70]. p62 is pri-
marily degraded by lysosomes and proteasomes [71], hence, this
could explain why incomplete degradation and accumulation of p62
occurs, and why CQ and 3-MA treatments have little effect on Bim de-
ﬁcient SMoR cells.
Previous studies demonstrated that Bim is sequestered by dynein
in healthy cells, and dissociates upon an apoptotic stimulus; provid-
ing a possible regulatory mechanism for the protein's apoptotic activ-
ity [18,72]. However, the viability of T cells transfected with a BH3
domain mutant of BimL was increased [32]. This suggested a possibil-
ity that beyond sequestering Bim, the interaction of BimL with dynein
facilitates the loading and perhaps fusion and positioning of lyso-
somes. In our study, IL-7 withdrawal induced vesicular aggregation
in T-cells containing Bim, while this was not observed in Bim deﬁ-
cient T-cells. This result is supported by studies with dynein-
deﬁcient cells in which endosomal and lysosomal content became
dispersed and lysosomes ceased to co-localize with microtubules
[73,74]. Moreover, knockdown of Huntingtin (Htt), a scaffolding pro-
tein that interacts with dynein, resulted in lysosomal accumulation
and aggregation, indicating that Htt was involved in the movement
of cargo. In contrast, we found that Bim deﬁciency resulted in dis-
persed vesicles and reduced aggregation, suggesting that Bim's role
may not be in cargo movement but rather in facilitating the fusion
of late endosomes/lysosomes. An example similar to Bim deﬁciency
was seen in a study using mice deﬁcient in Snapin, a SNARE-binding
protein. Deletion of Snapin caused accumulation of endocytic organ-
elles and impaired lysosomal function and maturity [75]. These re-
sults support the possibility that the dynein-binding motif on Bim,
KXTQT [19], renders the protein accessible as an adaptor for dynein
during normal T-cell function to facilitate the positioning and fusion
of lysosomal cargo.
The regulation of Bim transcription is mediated by the forkhead
transcription factor, FKHR-L1, in growth factor-deprived hematopoi-
etic cells [23,76]. This transcription factor, also known as Foxo3a,
translocates to the nucleus when the PI3-kinase/Akt pathway is
down-regulated in the absence of survival signals [77]. In neurons,
under growth factor deprivation, Bim was up-regulated but required
Jun N-terminal protein kinases (JNK) activation [67,78]. We show
that IL-7 induced basal levels of bim gene transcription, even in
non-apoptotic cells, and that the withdrawal of IL-7 further ampliﬁed
Bim synthesis. It may be that the JNK pathway and the PI3K pathway,
both shown to be active in response to IL-7 signaling [38,79,80], may
contribute to Bim expression in T-cells. Interestingly, engagement of
IL-7 induces the internalization and further recycling of the IL-7R by
proteasomes and lysosomes [81–83]. It is possible that Bim, by en-
abling lysosomal degradative activities, could play a role in regulating
the amount of IL-7R available for membrane expression. In support,
1890 S.M. Ruppert et al. / Biochimica et Biophysica Acta 1823 (2012) 1877–1893we found that in SMoR cells IL-7R levels were slightly higher. Further
evidence comes from a study in which cells were cultured with IL-7
and treated with a clathrin formation inhibitor [81]. As a result,
pAKT was reduced, which in turn, stimulated FKHR-1 translocation0
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generation of BimL mRNA but rather through splicing of the BimEL
mRNA. Hence BimEL was a pre-mRNA form of BimL [84]. Additionally,
deletion of exons containing phosphorylation sites, which are involved
in alternative splicing, can contribute to BimL expression. As an exam-
ple, in BimEL mutant mice lacking exon 3 which encodes sites of
MAPK phosphorylation, an increase in BimL protein expression oc-
curred [29]. In our study, we observed more BimL protein compared
to BimEL in the presence of IL-7, suggesting that BimL was being pro-
duced in preference to BimEL, perhaps through the splicingmechanism
described above. In the absence of IL-7, we noted increased total Bim
mRNA and more BimEL protein, indicating that the possible splicing of
BimEL to make BimL may only be occurring upon an IL-7 stimulus.
Our results indicated that the BimL isoformhas a non-apoptotic activ-
ity that supports lysosome maintenance. Bim and IL-7R double-deﬁcient
mice showed partial restoration of thymocyte development [17], while,
in a bonemarrow chimera, Bimdeﬁciency failed to fully reconstitute thy-
mocyte development [31]. Bim deﬁciency, in our studies, failed to rescue
adoptively transferred T-cells in IL-7−/− hosts. The inability of Bim deﬁ-
ciency to completely restore an immunodeﬁcient phenotype could in
part be explained by the redundancy of other pro-apoptotic proteins
like Bad or Bid. However, another perspective could be that Bim isoforms
have both apoptosis (BimEL, and BimS) and cell maintenance or auto-
phagic (BimL) activities. Other apoptosis-regulating proteins have been
shown to contribute to autophagy. For example, anti-apoptotic Bcl-2
bound Beclin-1 and inhibited autophagic induction, but overexpression
of pro-apoptotic protein, Bad, induced autophagy in human cells [85]. Ad-
ditionally, the lone Caenorhabditis elegans BH3-only protein, EGL-1, can
trigger autophagy [86]. In studies examining the individual isoforms of
Bim, in which both BimL and Bcl-2 were expressed, BimL could not over-
come the anti-apoptotic effects of Bcl-2 [87], perhaps because BimL could
not perform its non-apoptotic function as we have described. Moreover,
over-expression of BimL did not cause release of cytochrome c [87].
The implications of Bim isoforms having different cellular activi-
ties for disease treatments are signiﬁcant. In cancers with speciﬁc ge-
netic mutations, Bim levels were found to be predictive of the effect of
inhibitors targeting PI3K, HER2 or EGFR, but did not correlate with ef-
fectiveness to standard chemotherapeutics [88]. Efforts at developing
inhibitory Bim BH3-like mimetics for therapy only consider the pro-
apoptotic action of Bim mediated, for example, through the BH3 do-
main [89]. Our work suggests that Bim may be more complex, having
multiple isoforms and functions. An alternative approach could be the
design of compounds that target the Bim isoform-splicing mecha-
nisms. As a result, one could potentially control the generation of a
speciﬁc isoform to elicit the desired apoptotic (BimEL/S>BimL) or
autophagic (BimL>BimEL/S) outcome in a manner that is more effec-
tive than the targeting of total Bim.
5. Conclusions
In summary, our results revealed that the major isoforms of Bim
has deﬁned functions in the cell maintenance and the apoptotic pro-
cess occurring in T-cells responsive to IL-7. In T-cells receiving an IL-
7 signal, BimL plays an essential role in lysosomal positioning
through interactions with dynein that enable the formation of
autolysosomes during the degradative phase of autophagy. BimEL
associates with mitochondria in a pro-apoptotic manner, and ex-
pression of BimS further promotes the cell death process. BimL,
therefore, functions in the presence of IL-7 to support lysosomal
acidiﬁcation, while BimEL and BimS are active during IL-7 depriva-
tion to promote T-cell apoptosis.
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